Clinuvel Pharmaceuticals Limited Profit Margin

The latest profit margin for CLVLF is 38.11% as of December 2025. That compares with 37.28% in the prior-year period — up 2.2% year over year. That is above the Healthcare sector average of 10.58%. Investors often review this figure alongside Clinuvel Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLVLF's profit margin moved from 37.28% to 38.11% — a 2.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clinuvel Pharmaceuticals Limited's valuation or profitability profile.

Against Healthcare companies, CLVLF currently prints 38.11% for profit margin, while the sector average sits near 10.58%. That is roughly 260.2% above the sector mean. Large gaps often invite a closer look at Clinuvel Pharmaceuticals Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Clinuvel Pharmaceuticals Limited converts resources into returns. At 38.11%, CLVLF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 37.28% in the prior-year period — up 2.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLVLF's profit margin (38.11%), review year-over-year change from 37.28%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.